WO2024162514A1 - Method for preparing copper nanowire having high aspect ratio and copper nanowire prepared thereby - Google Patents
Method for preparing copper nanowire having high aspect ratio and copper nanowire prepared thereby Download PDFInfo
- Publication number
- WO2024162514A1 WO2024162514A1 PCT/KR2023/002436 KR2023002436W WO2024162514A1 WO 2024162514 A1 WO2024162514 A1 WO 2024162514A1 KR 2023002436 W KR2023002436 W KR 2023002436W WO 2024162514 A1 WO2024162514 A1 WO 2024162514A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copper
- aspect ratio
- solution
- acid
- nanowires
- Prior art date
Links
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 239000010949 copper Substances 0.000 title claims abstract description 45
- 229910052802 copper Inorganic materials 0.000 title claims abstract description 43
- 239000002070 nanowire Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title abstract description 9
- 239000012691 Cu precursor Substances 0.000 claims abstract description 15
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 15
- 239000003054 catalyst Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 150000002367 halogens Chemical class 0.000 claims abstract description 13
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000004886 process control Methods 0.000 abstract description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 63
- 239000000243 solution Substances 0.000 description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000003756 stirring Methods 0.000 description 14
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 13
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 13
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- NTKHLGAMTDSVMO-UHFFFAOYSA-N copper;oxalic acid Chemical compound [Cu].OC(=O)C(O)=O NTKHLGAMTDSVMO-UHFFFAOYSA-N 0.000 description 9
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 8
- 229910001431 copper ion Inorganic materials 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 239000003495 polar organic solvent Substances 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- -1 nitrate ions Chemical class 0.000 description 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- QYCVHILLJSYYBD-UHFFFAOYSA-L copper;oxalate Chemical compound [Cu+2].[O-]C(=O)C([O-])=O QYCVHILLJSYYBD-UHFFFAOYSA-L 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002161 passivation Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-SZSCBOSDSA-N 2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound OC[C@H](O)C1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-SZSCBOSDSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PXAJQJMDEXJWFB-UHFFFAOYSA-N acetone oxime Chemical compound CC(C)=NO PXAJQJMDEXJWFB-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000005290 antiferromagnetic effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- XNEQAVYOCNWYNZ-UHFFFAOYSA-L copper;dinitrite Chemical compound [Cu+2].[O-]N=O.[O-]N=O XNEQAVYOCNWYNZ-UHFFFAOYSA-L 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- JGUQDUKBUKFFRO-CIIODKQPSA-N dimethylglyoxime Chemical compound O/N=C(/C)\C(\C)=N\O JGUQDUKBUKFFRO-CIIODKQPSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- KOUDKOMXLMXFKX-UHFFFAOYSA-N sodium oxido(oxo)phosphanium hydrate Chemical compound O.[Na+].[O-][PH+]=O KOUDKOMXLMXFKX-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0547—Nanofibres or nanotubes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2301/00—Metallic composition of the powder or its coating
- B22F2301/10—Copper
Definitions
- the present invention relates to a method for producing a copper nanowire having a high aspect ratio and a copper nanowire produced thereby, and more particularly, to a method for producing a copper nanowire having a high aspect ratio of 1:180 or more and a copper nanowire produced thereby.
- Metal nanowires are one-dimensional nanomaterials that are attracting attention in various fields including catalysts, sensors, and electronic devices due to their excellent physical and chemical properties. Among them, copper not only has excellent electrical and thermal conductivity, but also has an advantage in price competitiveness due to its abundant reserves. In order for metal nanowires to be utilized in various fields, it is important to have a technology that satisfies physical properties such as shape uniformity, diameter, length, and aspect ratio while simultaneously producing them in mass quantities with excellent economic feasibility. In general, metal nanowires are induced to grow anisotropically due to the action of shape-controlling additives such as capping agents and halogen catalysts on metal seeds. In order to induce such growth, there have been problems in that many process steps are required and satisfactory yields are not obtained.
- Copper precursors commonly used in the synthesis of existing copper nanowires include copper compounds such as copper sulfate (CuSO 4 ), copper chloride (CuCl 2 ), and copper nitrate (Cu(NO 3 ) 2 ).
- CuSO 4 copper sulfate
- CuCl 2 copper chloride
- Cu(NO 3 ) 2 copper nitrate
- counterions such as chloride ions (Cl - ), sulfate ions (SO 4 2- ), and nitrate ions ((NO 3 ) 2- ) form a large amount of reaction by-products due to reactions with additives, making it difficult to maintain the composition before and after the reaction, and a complex post-treatment process is required, which may cause environmental problems.
- the copper nanowire manufacturing technology of the present invention aims to develop an economically advantageous copper nanowire manufacturing method that can reduce the generation of reaction by-products and process costs while dramatically improving productivity by applying CuC 2 O 4 as a copper precursor.
- the purpose is to provide a method for manufacturing high aspect ratio copper nanowires.
- the present invention aims to provide a high aspect ratio copper nanowire according to the above manufacturing method.
- the present invention provides a method for producing high aspect ratio copper nanowires having an aspect ratio of 1:180 or higher, comprising a fourth step of mixing and heating the first to third solutions to synthesize copper nanowires.
- the present invention provides a high aspect ratio copper nanowire according to the manufacturing method described above.
- the present invention can form copper nanowires of uniform thickness through a low-cost and simple solution process, and the formed pure copper has a yield of close to 60%.
- the present invention is the first study to apply CuC 2 O 4 as a copper precursor, and thus, not only can a cost-saving effect be expected, but also has the potential for high-yield copper nanowire synthesis through additional process control in the future.
- FIG. 1 is a schematic diagram showing the production of copper nanowires according to one embodiment of the present invention.
- FIG. 2 illustrates an SEM image of copper nanowires produced from copper oxalic acid according to one embodiment of the present invention.
- FIG. 3 illustrates an SEM image of copper nanowires produced from copper oxalic acid according to one embodiment of the present invention.
- Figure 4 illustrates an image of a copper shape produced after changing the solvent according to a comparative example of the present invention.
- Figure 5 illustrates an image of a copper shape produced when NaCl was not added according to a comparative example of the present invention.
- FIG. 6 illustrates the results of XRD analysis of copper nanowires produced from copper oxalic acid according to one embodiment of the present invention.
- a method for producing high aspect ratio copper nanowires having an aspect ratio of 1:180 or more comprising: a first step of forming a first solution containing a capping agent; a second step of forming a second solution containing a halogen catalyst and a reducing agent; a third step of forming a third solution containing a copper precursor compound; and a fourth step of mixing and heating the first to third solutions to synthesize copper nanowires.
- the first solution is prepared by dissolving a capping agent in a polar organic solvent at room temperature.
- the capping agent of the present invention is a compound that changes the assembly of growing copper atoms into an anisotropic state. It strongly adsorbs to a specific surface through a chemical reaction and inhibits growth through passivation, and the growth of nanowires occurs due to crystallization that continues while the cross-sectional surface is still exposed to the solution.
- Copper capping agents include polyvinylpyrrolidone (PVP), polyvinylalcohol (PVA), hexadecylamine, triethylenediamine, ethylenediamine, propane-1,3-diamine, butane-1,4-diamine, pentane-1,5-diamine, ethylenediamine tetraacetic acid, 1,2-cyclohexane diamine-N,N,N′,N′-tetraacetic acid, glycine, ascorbic acid, iminodiacetic acid, Nitrilotriacetic acid, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophane, tyrosine, valine, gallic acid, boric acid, acetic acid,
- PVP is a chain-shaped polymer material
- the molecular weight (Mw) is 10,000 to 60,000, preferably 30,000 to 60,000, and more preferably 40,000 to 60,000.
- Mw molecular weight
- Mw molecular weight
- Mw molecular weight
- Mw molecular weight
- a stable reaction can be induced. That is, when PVP having a large molecular weight is applied, an increase in the aspect ratio of the formed nanowire can be expected.
- the concentration of the capping agent added in the present invention is 50 to 154 mM, preferably 80 to 120 mM, more preferably 100 to 120 mM. If the capping agent is added in an amount less than 50 mM, the yield of nanowires may decrease due to an increase in the concentration of copper particles on which the capping agent does not act, and if it is added in an amount exceeding 154 mM, there is a problem in that passivation of all facets may be induced, resulting in generation in the form of nanoparticles.
- the solvent of the present invention is a polar organic solvent capable of dissolving all of the copper precursor, the capping agent, the halogen catalyst, and the reducing agent, and not only assists the action of the additive, but also assists the reduction of the metal precursor, and may be a polyhydric alcohol such as glycol or polyol.
- a polyhydric alcohol such as glycol or polyol.
- it may be ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, etc., and preferably, ethylene glycol may be used to promote the reduction reaction of copper.
- the second solution is prepared by dissolving a halogen catalyst and a reducing agent in a polar organic solvent.
- the halogen catalyst of the present invention is an additive containing a halogen ion (Cl - , Br -, etc.) and induces anisotropic growth. Separation into ions occurs in a polar organic solvent, and the halogen ion as an anion and the copper ion as a cation form an intermediate substance through bonding. This prevents supersaturation of free copper ions in the solution, thereby preventing random growth of particles. Through this ion provision rate control, a thermodynamically stable structure, a decahedron multiply-twinned particle, is formed.
- the multiply-twinned particle is a decahedron having five twin seeds with a mixture of ⁇ 111 ⁇ and ⁇ 100 ⁇ facets, and when a decahedral seed is generated, a nanowire having a pentagonal cross-section due to a single growth along the five-fold axis is generated.
- the concentration of the halogen catalyst is preferably 5 to 15 mM. If the halogen catalyst is added in an amount less than 5 mM, the concentration of copper ions in the solution increases, thereby accelerating the formation rate of copper nanoparticles. If the halogen catalyst is added in an amount exceeding 15 mM, the concentration of copper ions in the solution is drastically reduced, which causes a problem of limiting the growth of nanowires.
- the reducing agent of the present invention reacts with copper ions supplied from a copper precursor to form copper atoms.
- the reducing agent includes, but is not particularly limited to, at least one selected from the group consisting of fructose, potassium bromide, sodium borohydride, hydrazine, sodium chloride, sodium hydroxide, ammonium chloride, sodium phosphinate monohydrate, ascorbic acid, L(+)-ascorbic acid, an ascorbic acid derivative, oxalic acid, malic acid, formic acid, phosphite, glucose, sulfite, and cetytrimethyl ammonium bromide.
- ascorbic acid can be used as a reducing agent, and the concentration of the reducing agent is 30 to 80 mM, preferably 40 to 60 mM.
- the solvent of the second step is a polar organic solvent identical to the solvent used in the first step, and may be a polyhydric alcohol such as glycol or polyol.
- a polyhydric alcohol such as glycol or polyol.
- it may be ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, etc., and preferably, ethylene glycol may be used to promote the reduction reaction of copper.
- the third solution is prepared by dissolving a copper precursor compound in a polar organic solvent.
- the copper precursor compound of the present invention provides copper ions to form copper nanowires.
- the copper precursor may be copper sulfate, copper chloride, copper nitrate, copper nitrite, copper acetate, copper bromide, copper iodide, copper carbonate, copper oxalic acid, and the like, and preferably, copper oxalic acid, which is an inorganic material having anti-ferromagnetic properties, may be used.
- copper oxalic acid is used as a copper precursor, dissolved in an ethylene glycol solvent, and decomposed into copper ions and counter ions, oxalate ions (C 2 O 4 2- ), the copper ions are reduced to copper, and the oxalate ions are oxidized to CO 2 and removed through evaporation.
- the solvent of the third step is a polar organic solvent identical to the solvent used in the first and second steps, and may be a polyhydric alcohol such as glycol or polyol.
- a polyhydric alcohol such as glycol or polyol.
- it may be ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, etc., and preferably, ethylene glycol may be used to promote the reduction reaction of copper.
- the solvent since CuC 2 O 4 decomposes at a temperature of 250° C. or higher, the solvent must have a boiling point higher than the decomposition temperature.
- glycerol is a high-viscosity solvent with a boiling point of about 290° C., which has the advantage of being advantageous for reduction because it is higher than the decomposition temperature of CuC 2 O 4.
- high-viscosity solvents cause non-uniform chemical reactions, which limits the formation of nanowires.
- ethylene glycol has a boiling point of approximately 190°C , which is lower than the high decomposition temperature of CuC2O4 .
- This problem was solved by reducing the high reduction temperature of CuC2O4 by adding ascorbic acid, a reducing agent, and Cu nanowires were successfully synthesized when EG was applied.
- the first to third solutions formed above are mixed and heated to synthesize copper nanowires.
- each solution is heated to 60 to 100°C while stirring at 500 to 700 rpm. Then, the second solution is added to the first solution, and the stirring speed is increased to 600 to 800 rpm, and the third solution is added and the stirring speed is further increased to 700 to 900 rpm to induce uniform stirring.
- a surfactant may be further included in the mixed solution. The surfactant minimizes aggregation of copper nanowires, increases the length of the copper nanowires, and reduces the width of the copper nanowires.
- the surfactant usable in the present invention may include at least one selected from the group consisting of ethoxylate, alkoxylate, ethylene oxide, propylene oxide, and copolymers thereof, or at least one selected from the group consisting of sulfonate, sulfate, disulfonate salt, sulfosuccinate, phosphate ester, and fluorosurfactants, but is not particularly limited thereto.
- the final temperature of the solution thus mixed is increased to 140 to 180°C, most preferably 160°C, then heated for 3 to 5 hours and cooled to room temperature to terminate the reaction. Cooling is performed at room temperature, and an alcohol organic solvent (such as methanol, ethanol, acetone, etc.) is applied in a washing process to remove residual reaction by-products.
- a preferable alcohol organic solvent in the present invention may be methanol. Since the surface of the nanowire is covered with a capping agent, which is a polymer organic material, methanol plays a role in removing the capping layer. The reaction by-products on the surface of the copper nanowire can be completely removed with only two washing processes.
- a high aspect ratio copper nanowire is provided according to the above manufacturing method.
- the copper nanowires of the present invention have an average diameter of 190 to 200 nm, an average length of 65 to 70 nm, an aspect ratio of 1:180 or more, preferably 1:350 or more, and a final production yield of about 60%.
- the stirring speed was increased to 800 rpm to induce uniform stirring.
- the final solution temperature was increased to 160°C, it was heated for 4 hours, and then cooled to room temperature to terminate the reaction.
- the solution in which the reaction was completed was divided into 10 ml portions in 50 ml conical tubes, and 30 ml of methanol was supplied to each conical tube to perform centrifugation. The solvent was discarded, methanol was supplied again to redisperse the copper nanowires, and then the solvent was discarded to obtain the manufactured copper nanowires.
- the stirring speed was increased to 800 rpm to induce uniform stirring.
- the final solution temperature was increased to 160°C, it was heated for 4 hours, and then cooled to room temperature to terminate the reaction.
- the solution in which the reaction was completed was divided into 10 ml portions in 50 ml conical tubes, and 30 ml of methanol was supplied to each conical tube to perform centrifugation. The solvent was discarded, methanol was supplied again to redisperse the copper nanowires, and then the solvent was discarded to obtain the manufactured copper nanowires.
- a first solution was prepared by heating 50 ml of Glycerol in a 100 ml reactor to 200°C with stirring at 800 rpm. Then, 103 mM of PVP and 15 mM of NaCl were added at room temperature and dissolved in 10 ml of Glycerol to 100°C with stirring at 600 rpm. The first solution was added to the second solution and the temperature was raised to 250°C. Then, 12.4 mM of CuC 2 O 4 was added and heated for 1 hour, and the solution temperature was lowered to 100°C and additional heating was performed for 1 hour. Thereafter, the reaction was terminated by cooling to room temperature.
- the solution at the completion of the reaction was divided into 10 ml portions into 50 ml conical tubes, and 30 ml of methanol was supplied to each conical tube to perform centrifugation. After discarding the solvent, copper nanowires were redispersed by supplying methanol again, and then the solvent was discarded to obtain the manufactured copper nanowires.
- Copper nanowires were formed in the same manner as in Example 1 without adding NaCl.
- FIGS. 2 and 3 illustrate SEM images of copper nanowires manufactured from copper oxalic acid according to one embodiment of the present invention.
- copper nanowires manufactured using ethylene glycol as a solvent as in Examples 1 and 2 exhibited a nanowire shape, and it was confirmed that uniform copper nanowires whose thickness and length can be controlled by controlling the PVP molecular weight and the concentration of the halogen catalyst could be manufactured.
- Example 2 where copper nanowires were formed under optimized conditions based on Example 1, the average diameter was 192 nm, the average length was 68.10 ⁇ m, the aspect ratio was 354.08, and the final production yield was 57%.
- Fig. 4 illustrates an image of a copper shape produced after changing the solvent according to a comparative example of the present invention.
- copper produced using glycerol as a solvent, as in Comparative Example 1 exhibited a particle shape.
- Figure 5 illustrates an image of a copper shape produced when NaCl was not added according to a comparative example of the present invention. Referring to Figure 5, when NaCl was not used as in Comparative Example 2, incomplete reduction of copper oxalate and copper of an uneven shape were formed.
- FIG. 6 illustrates the results of XRD analysis of copper nanowires manufactured from copper oxalic acid according to one embodiment of the present invention.
- the copper nanowire according to Example 2 was a copper nanowire having an FCC structure having (111), (200), (220) planes, as copper peaks were observed at (111), (200), and (220).
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
Abstract
The present invention provides a method for preparing a copper nanowire having a high aspect ratio of an aspect ratio of 1:180 or more, the method comprising: a first step of forming a first solution containing a capping agent; a second step of forming a second solution containing a halogen catalyst and a reducing agent; a third step of forming a third solution containing a copper precursor compound; and a fourth step of mixing and heating the first solution to the third solution to synthesize a copper nanowire. The present invention may enable the formation of a copper nanowire with a uniform thickness through low-cost and simple solution processes, wherein pure copper has a yield close to 60 %. In addition, the present invention is the first study to apply CuC2O4 as a copper precursor, and not only is it expected to reduce costs, but also has the potential for high-yield copper nanowire synthesis through additional process control in the future.
Description
본 발명은 고 종횡비의 구리 나노와이어의 제조방법 및 이에 따른 구리 나노와이어에 관한 것으로, 더욱 상세하게는 1:180 이상의 고 종횡비를 갖는 구리 나노와이어의 제조방법 및 이에 따른 구리 나노와이어게 관한 것이다.The present invention relates to a method for producing a copper nanowire having a high aspect ratio and a copper nanowire produced thereby, and more particularly, to a method for producing a copper nanowire having a high aspect ratio of 1:180 or more and a copper nanowire produced thereby.
금속 나노와이어는 1 차원 나노 소재로 우수한 물리적 특성과 화학적 특성으로 인하여 촉매, 센서, 전자 소자를 비롯한 다양한 분야에 주목받고 있는 재료이다. 그 중에서 구리는 높은 전기 전도도 및 열전도도가 우수할 뿐만 아니라, 매장량이 풍부하여 가격 경쟁력에서 우위를 접할 수 있다. 금속 나노와이어가 다양한 분야에 활용되기 위해서는 형태의 균일성, 직경, 길이 및 종횡비와 같은 물성을 충족시킴과 동시에 우수한 경제성으로 대량 생산하는 기술이 중요하다. 일반적으로 금속 나노와이어는 금속 시드(Seed)에 캡핑제(Capping agent)와 할로겐 촉매와 같은 형상 제어 첨가제의 작용으로 인한 이방성 성장이 유도된다. 이러한 성장을 유도하기 위하여 다수의 공정 단계가 요구되며, 만족할만한 수율을 얻지 못하고 있다는 문제점이 있어왔다. 기존 구리 나노와이어 합성에 통상적으로 사용되는 구리 전구체는 황산구리(CuSO4), 염화구리(CuCl2), 질산구리(Cu(NO3)2)와 같은 구리 화합물이 사용되고 있다. 이러한 종래 기술의 문제점은 염화 이온 (Cl-), 황산 이온(SO4
2-), 질산 이온((NO3)2-)과 같은 카운터이온(counterion)과 결합하고 있는 화합물이 첨가제와의 반응으로 인하여 다량의 반응 부산물을 형성함에 따라 반응 전후의 조성 유지가 어려우며, 복잡한 후처리 공정이 요구되어 환경 문제가 발생할 수 있다는 문제점이 있다.Metal nanowires are one-dimensional nanomaterials that are attracting attention in various fields including catalysts, sensors, and electronic devices due to their excellent physical and chemical properties. Among them, copper not only has excellent electrical and thermal conductivity, but also has an advantage in price competitiveness due to its abundant reserves. In order for metal nanowires to be utilized in various fields, it is important to have a technology that satisfies physical properties such as shape uniformity, diameter, length, and aspect ratio while simultaneously producing them in mass quantities with excellent economic feasibility. In general, metal nanowires are induced to grow anisotropically due to the action of shape-controlling additives such as capping agents and halogen catalysts on metal seeds. In order to induce such growth, there have been problems in that many process steps are required and satisfactory yields are not obtained. Copper precursors commonly used in the synthesis of existing copper nanowires include copper compounds such as copper sulfate (CuSO 4 ), copper chloride (CuCl 2 ), and copper nitrate (Cu(NO 3 ) 2 ). The problem with these conventional technologies is that compounds that are combined with counterions such as chloride ions (Cl - ), sulfate ions (SO 4 2- ), and nitrate ions ((NO 3 ) 2- ) form a large amount of reaction by-products due to reactions with additives, making it difficult to maintain the composition before and after the reaction, and a complex post-treatment process is required, which may cause environmental problems.
이러한 종래 기술의 문제점을 보안하기 위한 본 발명의 구리 나노와이어 제조 기술은, CuC2O4를 구리 전구체로서 적용하여 반응 부산물 발생 감소 및 공정 비용 저감과 동시에 생산성을 획기적으로 향상시킬 수 있는 경제적으로 이점이 발생하는 구리 나노와이어 제조 방법을 개발하고자 한다.In order to solve the problems of the prior art, the copper nanowire manufacturing technology of the present invention aims to develop an economically advantageous copper nanowire manufacturing method that can reduce the generation of reaction by-products and process costs while dramatically improving productivity by applying CuC 2 O 4 as a copper precursor.
상기와 같은 문제를 해결하기 위하여, 고 종횡비의 구리 나노와이어의 제조방법을 제공하는 것을 목적으로 한다.In order to solve the above problems, the purpose is to provide a method for manufacturing high aspect ratio copper nanowires.
또한, 본 발명은 상기 제조 방법에 따른 고 종횡비의 구리 나노와이어를 제공하는 것을 목적으로 한다.In addition, the present invention aims to provide a high aspect ratio copper nanowire according to the above manufacturing method.
상기 목적을 달성하기 위하여 본 발명은,In order to achieve the above purpose, the present invention,
캡핑제를 포함하는 제 1용액을 형성하는 제 1단계;A first step of forming a first solution containing a capping agent;
할로겐 촉매 및 환원제를 포함하는 제 2용액을 형성하는 제 2단계;A second step of forming a second solution containing a halogen catalyst and a reducing agent;
구리 전구체 화합물을 포함하는 제 3용액을 형성하는 제 3단계;A third step of forming a third solution containing a copper precursor compound;
상기 제 1 내지 3 용액을 혼합하고 가열하여 구리 나노와이어를 합성하는 제 4단계;를 포함하는, 종횡비가 1:180 이상인 고 종횡비의 구리 나노와이어의 제조방법을 제공한다.The present invention provides a method for producing high aspect ratio copper nanowires having an aspect ratio of 1:180 or higher, comprising a fourth step of mixing and heating the first to third solutions to synthesize copper nanowires.
또한 상기 다른 목적을 달성하기 위하여 본 발명은 상기 제조방법에 따른 고 종횡비의 구리 나노와이어를 제공한다.In addition, in order to achieve the other objects described above, the present invention provides a high aspect ratio copper nanowire according to the manufacturing method described above.
본 발명은 저비용 및 간단한 용액 공정을 통해 균일한 두께의 구리 나노와이어를 형성할 수 있으며, 형성된 순수 구리는 60%에 가까운 수율을 갖는다. 또한, 본 발명은 CuC2O4를 구리 전구체로서 적용한 최초의 연구로서, 비용 절감 효과를 기대할 수 있을 뿐만 아니라 향후 추가적인 공정 제어를 통하여 고수율의 구리 나노와이어 합성을 위한 잠재력을 갖는다.The present invention can form copper nanowires of uniform thickness through a low-cost and simple solution process, and the formed pure copper has a yield of close to 60%. In addition, the present invention is the first study to apply CuC 2 O 4 as a copper precursor, and thus, not only can a cost-saving effect be expected, but also has the potential for high-yield copper nanowire synthesis through additional process control in the future.
도 1은 본 발명의 일 실시예에 따른 구리 나노와이어 생성을 나타낸 모식도를 도시한 것이다.FIG. 1 is a schematic diagram showing the production of copper nanowires according to one embodiment of the present invention.
도 2는 본 발명의 일 실시예에 따른 구리 옥살산으로부터 제작된 구리 나노와이어 SEM 이미지를 도시한 것이다.FIG. 2 illustrates an SEM image of copper nanowires produced from copper oxalic acid according to one embodiment of the present invention.
도 3은 본 발명의 일 실시예에 따른 구리 옥살산으로부터 제작된 구리 나노와이어 SEM 이미지를 도시한 것이다.FIG. 3 illustrates an SEM image of copper nanowires produced from copper oxalic acid according to one embodiment of the present invention.
도 4는 본 발명의 일 비교예에 따른 용매 변경 후, 제작된 구리 형상 이미지를 도시한 것이다.Figure 4 illustrates an image of a copper shape produced after changing the solvent according to a comparative example of the present invention.
도 5는 본 발명의 일 비교예에 따른 NaCl을 첨가하지 않았을 경우, 제작된 구리 형상 이미지를 도시한 것이다.Figure 5 illustrates an image of a copper shape produced when NaCl was not added according to a comparative example of the present invention.
도 6은 본 발명의 일 실시예에 따른 구리 옥살산으로부터 제작된 구리 나노와이어 XRD 분석 결과를 도시한 것이다.FIG. 6 illustrates the results of XRD analysis of copper nanowires produced from copper oxalic acid according to one embodiment of the present invention.
이하, 본 발명에 관하여 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 일측면에 따르면, 캡핑제를 포함하는 제 1용액을 형성하는 제 1단계; 할로겐 촉매 및 환원제를 포함하는 제 2용액을 형성하는 제 2단계; 구리 전구체 화합물을 포함하는 제 3용액을 형성하는 제 3단계; 상기 제 1 내지 3 용액을 혼합하고 가열하여 구리 나노와이어를 합성하는 제 4단계;를 포함하는, 종횡비가 1:180 이상인 고 종횡비의 구리 나노와이어의 제조방법을 제공한다.According to one aspect of the present invention, a method for producing high aspect ratio copper nanowires having an aspect ratio of 1:180 or more is provided, comprising: a first step of forming a first solution containing a capping agent; a second step of forming a second solution containing a halogen catalyst and a reducing agent; a third step of forming a third solution containing a copper precursor compound; and a fourth step of mixing and heating the first to third solutions to synthesize copper nanowires.
먼저, 제 1단계에 대하여 설명한다. 제 1용액은 상온에서 극성 유기 용매에 캡핑제를 용해시켜 제조한다.First, the first step is explained. The first solution is prepared by dissolving a capping agent in a polar organic solvent at room temperature.
본 발명의 캡핑제(capping agent)는 성장하는 구리 원자들의 조립을 이방성 상태로 변경하는 화합물이다. 특정 표면과 화학 반응을 통해 강하게 흡착하여 부동태화를 통한 성장을 억제하며, 횡단면 표면은 용액에 여전히 노출된 상태로 지속되는 결정화로 인하여 나노와이어의 성장이 발생한다. 구리 캡핑제는 폴리비닐피롤리돈(polyvinylpyrrolidone: PVP), 폴리비닐알코올 (polyvinylalcohol: PVA), 헥사데실아민(hexadecylamine), 트라이에틸렌다이아민(triethylenediamine), 에틸렌다이아민(ethylenediamine), 프로판-1,3-다이아민(propane-1,3-diamine), 부탄-1,4-다이아민(butane-1,4-diamine), 펜탄-1,5-다이아민(pentane-1,5-diamine), 에틸렌다이아민테트라아세트산(ethylenediamine tetraacetic acid), 1,2-사이클로헥산다이아민-N,N,N′,N′-테트라아세트산(1,2-cyclohexane diamine-N,N,N,N′-tetraacetic acid), 글리신(glycine), 아스코르브산(ascorbic acid), 이미노다이아세트산(iminodiacetic acid), 니트릴로트라이아세트산(nitrilotriacetic acid), 알라닌(alanine), 아르기닌(arginine), 아스파라긴(asparagine), 아스파르트산(aspartic acid), 시스테인(cysteine), 글루탐산(glutamic acid), 글루타민(glutamine), 히스티딘(histidine), 이소류신(isoleucine), 류신(leucine), 라이신(lysine), 메티오닌(methionine), 페닐알라닌(phenylalanine), 프롤린(proline), 세린(serine), 쓰레오닌(threonine), 트립토판(tryptophane), 티로신(tyrosine), 발린(valine), 갈산(galic acid), 붕산(boric acid), 아세트산(acetic acid), 아세톤 옥심(acetone oxime), 아크릴산(acrylic acid), 아디프산(adipic acid), 베타인(betaine), 다이메틸 글리옥심(dimethylgloxime), 포름산(formic acid), 푸마르산(fumaric acid), 글루콘산(gluconic acid), 글루타르산(glutaric acid), 글리세르산(glyceric acid), 글리콜산(glycollic acid), 글리옥실산(glyoxylic acid), 이소프탈산(isophthalic acid), 이타콘산(itaconic acid), 락트산(lactic acid), 말레산(maleic acid), 말레산 무수물(malelic anhydride), 말산(malic acid), 말론산(malonic acid), 만델산(mandelic acid), 2,4-펜탄다이온(2,4-pentandione), 페닐아세트산(phenylacetic acid), 프탈산(phthalic acid), 프롤린(proline), 프로피온산(propionic acid), 피로카테골(pyrocatechol), 피로멜리트산(pyromellitic acid), 퀸산(quinic acid), 소르비톨(sorbitol), 숙신산(succinic acid), 타르타르산(tartaric acid), 테레프탈산(terephthalic acid), 트라이멜리트산(trimellitic acid), 트라이메스산(trimesic acid), 자일리톨(xylitol), 이들의 염 및 이들의 유도체로 이루어진 군으로부터 선택된 1종 이상을 포함하나 특별히 이에 한정되지 않는다. 본 발명에서 구리 캡핑제는 폴리비닐피롤리돈(PVP) 및 폴리비닐알코올(PVA), 가장 바람직하게는 폴리비닐피롤리돈을 사용한다.The capping agent of the present invention is a compound that changes the assembly of growing copper atoms into an anisotropic state. It strongly adsorbs to a specific surface through a chemical reaction and inhibits growth through passivation, and the growth of nanowires occurs due to crystallization that continues while the cross-sectional surface is still exposed to the solution. Copper capping agents include polyvinylpyrrolidone (PVP), polyvinylalcohol (PVA), hexadecylamine, triethylenediamine, ethylenediamine, propane-1,3-diamine, butane-1,4-diamine, pentane-1,5-diamine, ethylenediamine tetraacetic acid, 1,2-cyclohexane diamine-N,N,N′,N′-tetraacetic acid, glycine, ascorbic acid, iminodiacetic acid, Nitrilotriacetic acid, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophane, tyrosine, valine, gallic acid, boric acid, acetic acid, acetone oxime, acrylic acid, adipic acid, betaine, dimethyl Glyoxime, formic acid, fumaric acid, gluconic acid, glutaric acid, glyceric acid, glycolic acid, glyoxylic acid, isophthalic acid, itaconic acid, lactic acid, maleic acid, maleic anhydride, malic acid, malonic acid, mandelic acid, 2,4-pentandione, phenylacetic acid, phthalic acid, proline, propionic acid, pyrocatechol, pyromellitic acid, quinic acid, Includes at least one selected from the group consisting of sorbitol, succinic acid, tartaric acid, terephthalic acid, trimellitic acid, trimesic acid, xylitol, salts thereof, and derivatives thereof, but is not particularly limited thereto. In the present invention, the copper capping agent uses polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA), most preferably polyvinylpyrrolidone.
본 발명의 일 실시예에서 사용한 PVP는 사슬 형태의 고분자 물질로, FCC 구조의 구리 시드의 {100}면에 PVP의 Carbonyl group(C=O)이 강하게 흡착하여 {111}면의 횡단면이 형성되며, <110> 방향으로 성장한다. 분자량(Mw)은 10000 내지 60000, 바람직하게는 30000 내지 60000, 더욱 바람직하게는 40000 내지 60000이다. PVP의 분자량이 증가할수록 Cu2+과 Carbonyl group(C=O)의 강한 화학적 흡착이 이루어지고, 우수한 표면 코팅으로 구리 시드 표면에 안정적으로 흡착한다. 또한, 용액 내 점도를 향상시키기 때문에 안정적인 반응을 이끌어낼 수 있다. 즉, 분자량이 큰 PVP를 적용 시, 형성된 나노와이어의 종횡비의 증가를 기대할 수 있다.In one embodiment of the present invention, PVP is a chain-shaped polymer material, and the Carbonyl group (C=O) of PVP is strongly adsorbed to the {100} plane of the copper seed having the FCC structure, forming a cross-section of the {111} plane and growing in the <110> direction. The molecular weight (Mw) is 10,000 to 60,000, preferably 30,000 to 60,000, and more preferably 40,000 to 60,000. As the molecular weight of PVP increases, a strong chemical adsorption of Cu2 + and the Carbonyl group (C=O) occurs, and it is stably adsorbed on the surface of the copper seed with excellent surface coating. In addition, since it improves the viscosity in the solution, a stable reaction can be induced. That is, when PVP having a large molecular weight is applied, an increase in the aspect ratio of the formed nanowire can be expected.
또한, 본 발명에서 첨가하는 캡핑제의 농도는 50 내지 154mM이며, 바람직하게는 80 내지 120 mM, 더 바람직하게는 100 내지 120mM이다. 캡핑제를 50mM 미만으로 첨가할 경우 캡핑제가 작용하지 않는 구리 입자의 농도 증가로 인해 나노와이어의 수율이 감소할 수 있으며, 154mM 초과하여 첨가할 경우 모든 facet의 부동태화를 유도하여 나노 입자 형태로 생성될 수 있다는 문제가 있다.In addition, the concentration of the capping agent added in the present invention is 50 to 154 mM, preferably 80 to 120 mM, more preferably 100 to 120 mM. If the capping agent is added in an amount less than 50 mM, the yield of nanowires may decrease due to an increase in the concentration of copper particles on which the capping agent does not act, and if it is added in an amount exceeding 154 mM, there is a problem in that passivation of all facets may be induced, resulting in generation in the form of nanoparticles.
본 발명의 용매는 구리 전구체, 캡핑제, 할로겐 촉매 및 환원제를 모두 용해시킬 수 있는 극성 유기 용매로, 첨가제의 작용을 도울 뿐만 아니라 금속 전구체의 환원을 돕는 역할을 하며, 글리콜, 폴리올과 같은 다가 알코올일 수 있다. 예를 들어, 에틸렌 글리콜, 1,2-프로필렌 글리콜, 1,3-프로필렌글리콜 등일 수 있으며, 바람직하게는 구리의 환원 반응 촉진을 위해 에틸렌 글리콜이 사용될 수 있다.The solvent of the present invention is a polar organic solvent capable of dissolving all of the copper precursor, the capping agent, the halogen catalyst, and the reducing agent, and not only assists the action of the additive, but also assists the reduction of the metal precursor, and may be a polyhydric alcohol such as glycol or polyol. For example, it may be ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, etc., and preferably, ethylene glycol may be used to promote the reduction reaction of copper.
다음으로, 제 2단계에 대하여 설명한다. 제 2용액은 극성 유기 용매에 할로겐 촉매 및 환원제를 용해시켜 제조한다.Next, the second step is described. The second solution is prepared by dissolving a halogen catalyst and a reducing agent in a polar organic solvent.
본 발명의 할로겐 촉매는 할로겐 이온 (Cl-, Br- 등)을 포함하는 첨가제이며, 이방성 성장을 유도한다. 극성 유기 용매에서 이온으로 분리가 발생하며, 음이온의 할로겐 이온과 양이온의 구리 이온은 결합을 통하여 중간물질을 형성한다. 이는 용액 내 자유 구리 이온과포화를 방지하여 입자의 무작위한 성장을 방지하는 역할을 한다. 이러한 이온 제공 속도 제어를 통하여 열역학적으로 안정한 구조인 십면체(Decahedron) 다중쌍정입자(Multiply-twinned particle)를 형성한다. 다중쌍정입자는 {111} 및 {100} facet이 혼합된 5개의 트윈 시드 (Twin seed)를 가진 십면체이며, 십면체 시드(Decahedral seed)가 생성되면 five-fold 축을 따라 단일 성장으로 인한 오각형 단면을 가지는 나노와이어가 생성된다.The halogen catalyst of the present invention is an additive containing a halogen ion (Cl - , Br -, etc.) and induces anisotropic growth. Separation into ions occurs in a polar organic solvent, and the halogen ion as an anion and the copper ion as a cation form an intermediate substance through bonding. This prevents supersaturation of free copper ions in the solution, thereby preventing random growth of particles. Through this ion provision rate control, a thermodynamically stable structure, a decahedron multiply-twinned particle, is formed. The multiply-twinned particle is a decahedron having five twin seeds with a mixture of {111} and {100} facets, and when a decahedral seed is generated, a nanowire having a pentagonal cross-section due to a single growth along the five-fold axis is generated.
본 발명에서 할로겐 촉매의 농도는 5 내지 15mM인 것이 바람직하며, 할로겐 촉매를 5mM 미만으로 첨가할 경우 용액 내 구리 이온의 농도가 증가하여 구리 나노입자의 형성 속도가 촉진되며, 15mM 초과하여 첨가할 경우 용액 내 구리 이온 농도를 극단적으로 감소시켜 나노와이어의 성장을 제한하는 문제가 발생한다.In the present invention, the concentration of the halogen catalyst is preferably 5 to 15 mM. If the halogen catalyst is added in an amount less than 5 mM, the concentration of copper ions in the solution increases, thereby accelerating the formation rate of copper nanoparticles. If the halogen catalyst is added in an amount exceeding 15 mM, the concentration of copper ions in the solution is drastically reduced, which causes a problem of limiting the growth of nanowires.
본 발명의 환원제는 구리 전구체로부터 공급된 구리이온과 반응하여 구리 원자를 형성한다. 환원제는 프룩토오스(fructose), 포타슘 브로마이드(potassium bromide), 소듐 브로하아드라이드(sodium borohydride), 하이드라진(hydrazine), 소듐 클로라이드(sodium chloride), 소듐 하이드록사이드(sodium hydroxide), 암모늄 클로라이드(ammonium chloride), 소듐 포스피네이트 모노하이드레이트(sodium phosphinate monohydrate), 아스코르빅산(ascorbic acid), L(+)-아스코르빅산(L(+)-ascorbic acid), 아스코르빅산 유도체(ascorbic acid derivative), 옥살산oxalic acid), 말산(malic acid), 포름산(formic acid), 포스파이트(phosphite), 글루코오스(glucose), 설파이트(sulfite) 및 세틸트리메틸암모늄브로마이드(cetytrimethyl ammonium bromide) 이루어진 군으로부터 선택된 1종 이상을 포함하나 특별히 이에 한정되는 것은 아니다. 본 발명에서 환원제는 아스코르빅산(ascorbic acid)을 사용할 수 있으며, 환원제의 농도는 30 내지 80 mM, 바람직하게는 40 내지 60mM이다. The reducing agent of the present invention reacts with copper ions supplied from a copper precursor to form copper atoms. The reducing agent includes, but is not particularly limited to, at least one selected from the group consisting of fructose, potassium bromide, sodium borohydride, hydrazine, sodium chloride, sodium hydroxide, ammonium chloride, sodium phosphinate monohydrate, ascorbic acid, L(+)-ascorbic acid, an ascorbic acid derivative, oxalic acid, malic acid, formic acid, phosphite, glucose, sulfite, and cetytrimethyl ammonium bromide. In the present invention, ascorbic acid can be used as a reducing agent, and the concentration of the reducing agent is 30 to 80 mM, preferably 40 to 60 mM.
제 2단계의 용매는 제 1단계에서 사용한 용매와 동일한 극성 유기 용매이며, 글리콜, 폴리올과 같은 다가 알코올일 수 있다. 예를 들어, 에틸렌 글리콜, 1,2-프로필렌 글리콜, 1,3-프로필렌글리콜 등일 수 있으며, 바람직하게는 구리의 환원 반응 촉진을 위해 에틸렌 글리콜이 사용될 수 있다.The solvent of the second step is a polar organic solvent identical to the solvent used in the first step, and may be a polyhydric alcohol such as glycol or polyol. For example, it may be ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, etc., and preferably, ethylene glycol may be used to promote the reduction reaction of copper.
다음으로, 제 3단계에 대하여 설명한다. 제 3용액은 극성 유기 용매에 구리 전구체 화합물을 용해시켜 제조한다.Next, the third step is described. The third solution is prepared by dissolving a copper precursor compound in a polar organic solvent.
본원발명의 구리 전구체 화합물은 구리 이온을 제공하여 구리 나노와이어를 형성한다. 구리 전구체는 황산구리, 염화구리, 질산구리, 아질산구리, 아세트산구리, 브롬화구리, 요오드화구리, 탄산구리 및 구리 옥살산 등일 수 있으며, 바람직하게는 반-강자성 특성을 가진 무기 소재인 구리 옥살산이 사용될 수 있다.The copper precursor compound of the present invention provides copper ions to form copper nanowires. The copper precursor may be copper sulfate, copper chloride, copper nitrate, copper nitrite, copper acetate, copper bromide, copper iodide, copper carbonate, copper oxalic acid, and the like, and preferably, copper oxalic acid, which is an inorganic material having anti-ferromagnetic properties, may be used.
본 발명의 일 실시예에서는 구리옥살산이 구리 전구체로 사용되고, 에틸렌 글리콜 용매에 용해되어 구리 이온과 카운터 이온인 옥살산 이온(C2O4
2-)으로 분해가 되며, 구리 이온은 구리로서 환원되며 옥살산 이온은 CO2로 산화되어 증발을 통해 제거된다.In one embodiment of the present invention, copper oxalic acid is used as a copper precursor, dissolved in an ethylene glycol solvent, and decomposed into copper ions and counter ions, oxalate ions (C 2 O 4 2- ), the copper ions are reduced to copper, and the oxalate ions are oxidized to CO 2 and removed through evaporation.
제 3단계의 용매는 제 1, 2단계에서 사용한 용매와 동일한 극성 유기 용매이며, 글리콜, 폴리올과 같은 다가 알코올일 수 있다. 예를 들어, 에틸렌 글리콜, 1,2-프로필렌 글리콜, 1,3-프로필렌글리콜 등일 수 있으며, 바람직하게는 구리의 환원 반응 촉진을 위해 에틸렌 글리콜이 사용될 수 있다.The solvent of the third step is a polar organic solvent identical to the solvent used in the first and second steps, and may be a polyhydric alcohol such as glycol or polyol. For example, it may be ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, etc., and preferably, ethylene glycol may be used to promote the reduction reaction of copper.
본 발명의 일 실시예와 같이 구리 전구체로 구리옥살산을 사용할 경우, 250℃ 이상의 온도에서 CuC2O4는 분해되기 때문에, 분해 온도 이상의 끓는점을 가지는 용매여야 한다. 예를 들어, 글리세롤은 끓는점이 약 290℃인 고점도 용매로, CuC2O4 분해 온도보다 높아 환원에 유리하다는 장점이 있으나, 고점도의 용매는 불균일한 화학 반응을 일으켜 나노와이어 형성에 한계가 발생한다는 문제가 있다.When copper oxalic acid is used as a copper precursor as in one embodiment of the present invention, since CuC 2 O 4 decomposes at a temperature of 250° C. or higher, the solvent must have a boiling point higher than the decomposition temperature. For example, glycerol is a high-viscosity solvent with a boiling point of about 290° C., which has the advantage of being advantageous for reduction because it is higher than the decomposition temperature of CuC 2 O 4. However, there is a problem in that high-viscosity solvents cause non-uniform chemical reactions, which limits the formation of nanowires.
반면, 에틸렌 글리콜(EG)은 끓는점이 약 190℃로 CuC2O4의 높은 분해온도에 비해 낮은 편이다. 환원제인 Ascorbic acid를 첨가하여 CuC2O4의 높은 환원 온도를 감소시켜 이를 해결하였으며, EG 적용 시 성공적으로 Cu nanowire가 합성된다.On the other hand, ethylene glycol (EG) has a boiling point of approximately 190°C , which is lower than the high decomposition temperature of CuC2O4 . This problem was solved by reducing the high reduction temperature of CuC2O4 by adding ascorbic acid, a reducing agent, and Cu nanowires were successfully synthesized when EG was applied.
다음으로, 제 4단계에 대하여 설명한다. 상기 형성한 제 1 내지 3 용액을 혼합하고 가열하여 구리 나노와이어를 합성한다.Next, the fourth step is described. The first to third solutions formed above are mixed and heated to synthesize copper nanowires.
우선, 상기 제 1 내지 3단계에서 형성한 각 용액들을 혼합하기 전, 각각의 용액들을 500 내지 700 rpm으로 교반하면서 60 내지 100℃까지 가열한다. 그런 다음, 제 1용액에 제 2용액을 투입하고 600 내지 800rpm으로 교반 속도를 증가시키고, 제 3용액을 투입하여 700 내지 900rpm으로 교반 속도를 더 증가시켜 균일한 교반을 유도한다. 이때, 제 1 내지 3용액을 혼합시 혼합 용액에 계면활성제를 더 포함할 수 있다. 계면활성제는 구리 나노선의 응집을 최소화하고 구리 나노선의 길이를 증가시키고 구리나노선의 폭을 감소시킨다. 본 발명에서 사용 가능한 계면활성제는 에톡실레이트(ethoxylate), 알콕실레이트(alkoxilate), 에틸렌 옥사이드(ethylene oxide), 프로필렌 옥사이드(propylene oxide) 및 이들의 공중합체로 이루어진 군으로부터 선택된 1종 이상이거나, 설포네이트(sulfonate), 설페이트(sulfate), 디설포네이트 염(disulfonate salt), 설포숙시네이트(sulfosuccinate), 포스페이트 에스테르(phosphate ester) 및 플루오르 계면활성제로 이루어진 군으로부터 선택된 1종 이상을 포함할 수 있으나, 특별히 이에 한정되는 것은 아니다.First, before mixing the respective solutions formed in the first to third steps, each solution is heated to 60 to 100°C while stirring at 500 to 700 rpm. Then, the second solution is added to the first solution, and the stirring speed is increased to 600 to 800 rpm, and the third solution is added and the stirring speed is further increased to 700 to 900 rpm to induce uniform stirring. At this time, when mixing the first to third solutions, a surfactant may be further included in the mixed solution. The surfactant minimizes aggregation of copper nanowires, increases the length of the copper nanowires, and reduces the width of the copper nanowires. The surfactant usable in the present invention may include at least one selected from the group consisting of ethoxylate, alkoxylate, ethylene oxide, propylene oxide, and copolymers thereof, or at least one selected from the group consisting of sulfonate, sulfate, disulfonate salt, sulfosuccinate, phosphate ester, and fluorosurfactants, but is not particularly limited thereto.
이렇게 혼합된 용액의 최종 온도를 140 내지 180℃, 가장 바람직하게는 160℃까지 승온 후, 3 내지 5시간 동안 가열하고 상온으로 냉각시켜 반응을 종료한다. 상온에서 냉각을 진행하며 알코올 유기 용매(Methanol, Ethanol, Acetone 등)를 수세 공정에 적용하여 잔류 반응 부산물을 제거한다. 본 발명에서 바람직한 알코올 유기용매는 메탄올일 수 있다. 나노와이어 표면은 고분자 유기물인 캡핑제로 덮여있어, 메탄올이 캡핑층을 제거해주는 역할을 한다. 단 2회의 수세 공정 적용만으로도 구리 나노와이어 표면의 반응 부산물을 완전히 제거할 수 있다.The final temperature of the solution thus mixed is increased to 140 to 180°C, most preferably 160°C, then heated for 3 to 5 hours and cooled to room temperature to terminate the reaction. Cooling is performed at room temperature, and an alcohol organic solvent (such as methanol, ethanol, acetone, etc.) is applied in a washing process to remove residual reaction by-products. A preferable alcohol organic solvent in the present invention may be methanol. Since the surface of the nanowire is covered with a capping agent, which is a polymer organic material, methanol plays a role in removing the capping layer. The reaction by-products on the surface of the copper nanowire can be completely removed with only two washing processes.
본 발명의 다른 일측면에 따르면, 상기 제조방법에 따른 고 종횡비의 구리 나노와이어를 제공한다.According to another aspect of the present invention, a high aspect ratio copper nanowire is provided according to the above manufacturing method.
본 발명의 구리 나노와이어는 평균 직경 190 내지 200 nm, 평균 길이 65 내지 70 nm, 종횡비 1:180 이상, 바람직하게는 1: 350 이상, 최종 생산율 약 60%이다.The copper nanowires of the present invention have an average diameter of 190 to 200 nm, an average length of 65 to 70 nm, an aspect ratio of 1:180 or more, preferably 1:350 or more, and a final production yield of about 60%.
이하, 본 명세서를 구체적으로 설명하기 위해 실시예 및 비교예를 들어 상세하게 설명하기로 한다. 그러나, 본 명세서에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 명세서의 범위가 아래에서 기술하는 실시예들에 한정되는 것으로 해석되지 않는다. 본 명세서의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 명세서를 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, in order to specifically explain this specification, examples and comparative examples will be given in detail. However, the examples according to this specification may be modified in various different forms, and the scope of this specification is not construed as being limited to the examples described below. The examples of this specification are provided to more completely explain this specification to a person having average knowledge in the art.
<실시예><Example>
실시예 1 - 구리나노와이어의 제조Example 1 - Preparation of copper nanowires
100ml 반응기에 PVP(MW=10000) 103mM을 상온에서 EG(Ethylene Glycol) 40ml에 용해시켜 제 1용액을 제조하고, 50ml 반응기에서 EG 10ml에 NaCl 10mM, AA 52mM을 용해시켜 제 2용액을 제조하였다. 그런 다음, 50ml 반응기에서 EG 10ml에 12.4mM의 CuC2O4를 용해시켜 제3용액을 제조하고, 각 용액을 80℃까지 600rpm으로 교반하면서 가열한 후, 제1용액에 제2용액을 투입하고 700rpm으로 교반 속도를 증가시켰다. 제 3용액 투입 후, 800rpm으로 교반 속도를 증가시켜 균일한 교반을 유도하였다. 최종 용액 온도를 160℃까지 승온 후 4시간 동안 가열한 다음, 상온으로 냉각시켜 반응을 종료하였다. 이후, 반응이 종료된 용액을 50ml 코니칼튜브에 10ml씩 나누었으며 각 코니칼튜브에 30ml 메탄올을 공급하여 원심분리를 진행하였다. 용매를 버린 다음, 다시 메탄올을 공급하여 구리 나노와이어를 재분산시킨 후 용매를 버림으로서 제조된 구리 나노와이어를 수득하였다.A first solution was prepared by dissolving 103 mM PVP (M W = 10000) in 40 ml of EG (Ethylene Glycol) in a 100 ml reactor at room temperature, and a second solution was prepared by dissolving 10 mM NaCl and 52 mM AA in 10 ml of EG in a 50 ml reactor. Then, a third solution was prepared by dissolving 12.4 mM CuC 2 O 4 in 10 ml of EG in a 50 ml reactor, and each solution was heated to 80°C with stirring at 600 rpm, then the second solution was added to the first solution, and the stirring speed was increased to 700 rpm. After the third solution was added, the stirring speed was increased to 800 rpm to induce uniform stirring. After the final solution temperature was increased to 160°C, it was heated for 4 hours, and then cooled to room temperature to terminate the reaction. Afterwards, the solution in which the reaction was completed was divided into 10 ml portions in 50 ml conical tubes, and 30 ml of methanol was supplied to each conical tube to perform centrifugation. The solvent was discarded, methanol was supplied again to redisperse the copper nanowires, and then the solvent was discarded to obtain the manufactured copper nanowires.
실시예 2 - 구리나노와이어의 제조Example 2 - Preparation of copper nanowires
100ml 반응기에 PVP(MW=55000) 103mM을 상온에서 EG(Ethylene Glycol) 40ml에 용해시켜 제1용액을 제조하고, 50ml 반응기에서 EG 10ml에 NaCl 15mM, AA 52mM을 용해시켜 제2용액을 제조하였다. 그런 다음, 50ml 반응기에서 EG 10ml에 12.4mM의 CuC2O4를 용해시켜 제3용액을 제조하고, 각 용액을 80℃까지 600rpm으로 교반하면서 가열한 후, 제1용액에 제2용액을 투입하고 700rpm으로 교반 속도를 증가시켰다. 제3용액 투입 후, 800rpm으로 교반 속도를 증가시켜 균일한 교반을 유도하였다. 최종 용액 온도를 160℃까지 승온 후 4시간 동안 가열한 다음, 상온으로 냉각시켜 반응을 종료하였다. 이후, 반응이 종료된 용액을 50ml 코니칼튜브에 10ml씩 나누었으며 각 코니칼튜브에 30ml 메탄올을 공급하여 원심분리를 진행하였다. 용매를 버린 다음, 다시 메탄올을 공급하여 구리 나노와이어를 재분산시킨 후 용매를 버림으로서 제조된 구리 나노와이어를 수득하였다.A first solution was prepared by dissolving 103 mM PVP (M W = 55000) in 40 ml of EG (Ethylene Glycol) in a 100 ml reactor at room temperature, and a second solution was prepared by dissolving 15 mM NaCl and 52 mM AA in 10 ml of EG in a 50 ml reactor. Then, a third solution was prepared by dissolving 12.4 mM CuC 2 O 4 in 10 ml of EG in a 50 ml reactor, and each solution was heated to 80°C with stirring at 600 rpm, then the second solution was added to the first solution, and the stirring speed was increased to 700 rpm. After the third solution was added, the stirring speed was increased to 800 rpm to induce uniform stirring. After the final solution temperature was increased to 160°C, it was heated for 4 hours, and then cooled to room temperature to terminate the reaction. Afterwards, the solution in which the reaction was completed was divided into 10 ml portions in 50 ml conical tubes, and 30 ml of methanol was supplied to each conical tube to perform centrifugation. The solvent was discarded, methanol was supplied again to redisperse the copper nanowires, and then the solvent was discarded to obtain the manufactured copper nanowires.
비교예 1 - 용매를 달리한 구리나노와이어의 제조Comparative Example 1 - Preparation of copper nanowires using different solvents
100ml 반응기에 50ml Glycerol을 200℃까지 800rpm으로 교반하며 승온시켜 제1용액을 제조하였다. 이후 PVP 103mM와 NaCl 15mM을 상온에서 첨가하여 Glycerol 10ml에 100℃까지 600rpm으로 교반하며 용해시켜 제1용액을 제2용액에 첨가하고 250℃까지 승온시켰다. 그런 다음, 12.4mM의 CuC2O4를 첨가하여 1시간 동안 가열하고 100℃로 용액 온도를 하강시켜 1시간 동안 추가 가열을 진행하였다. 이후, 상온으로 냉각시켜 반응을 종료하였다. 반응이 종료된 용액을 50ml 코니칼튜브에 10ml씩 나누었으며, 각 코니칼튜브에 30ml 메탄올을 공급하여 원심분리를 진행하였다. 용매를 버린 다음, 다시 메탄올을 공급하여 구리 나노와이어를 재분산 시킨 후 용매를 버림으로서 제조된 구리 나노와이어를 수득하였다.A first solution was prepared by heating 50 ml of Glycerol in a 100 ml reactor to 200°C with stirring at 800 rpm. Then, 103 mM of PVP and 15 mM of NaCl were added at room temperature and dissolved in 10 ml of Glycerol to 100°C with stirring at 600 rpm. The first solution was added to the second solution and the temperature was raised to 250°C. Then, 12.4 mM of CuC 2 O 4 was added and heated for 1 hour, and the solution temperature was lowered to 100°C and additional heating was performed for 1 hour. Thereafter, the reaction was terminated by cooling to room temperature. The solution at the completion of the reaction was divided into 10 ml portions into 50 ml conical tubes, and 30 ml of methanol was supplied to each conical tube to perform centrifugation. After discarding the solvent, copper nanowires were redispersed by supplying methanol again, and then the solvent was discarded to obtain the manufactured copper nanowires.
비교예 2 - 할로겐 촉매 비사용 구리나노와이어의 제조Comparative Example 2 - Preparation of copper nanowires without using halogen catalyst
NaCl을 첨가하지 않고, 실시예 1과 동일한 방법으로 구리 나노와이어를 형성하였다.Copper nanowires were formed in the same manner as in Example 1 without adding NaCl.
실험예 1 - 형상 분석Experimental Example 1 - Shape Analysis
상기 실시예 1 및 2에서 제조한 구리 나노와이어 형상을 SEM을 이용하여 관찰하였다.The shape of the copper nanowires manufactured in Examples 1 and 2 above was observed using SEM.
실험예 2 - XRD 분석Experimental Example 2 - XRD Analysis
상기 실시예 2에서 제조한 구리 나노와이어에 대하여 XRD 분석을 수행하였다.XRD analysis was performed on the copper nanowires manufactured in Example 2 above.
<결과 및 평가><Results and Evaluation>
형상 분석Shape Analysis
도 2 및 3은 본 발명의 일 실시예에 따른 구리 옥살산으로부터 제작된 구리 나노와이어 SEM 이미지를 도시한 것이다. 도 2 및 3을 참조하면, 실시예 1 및 2에서와 같이 Ethylene Glycol을 용매로서 제조된 구리로 나노와이어 형상을 나타내었으며, PVP 분자량 및 할로겐 촉매의 농도를 조절함으로써 두께 및 길이를 조절할 수 있는 균일한 구리 나노 와이어를 제조할 수 있음을 확인하였다.FIGS. 2 and 3 illustrate SEM images of copper nanowires manufactured from copper oxalic acid according to one embodiment of the present invention. Referring to FIGS. 2 and 3, copper nanowires manufactured using ethylene glycol as a solvent as in Examples 1 and 2 exhibited a nanowire shape, and it was confirmed that uniform copper nanowires whose thickness and length can be controlled by controlling the PVP molecular weight and the concentration of the halogen catalyst could be manufactured.
실시예 1을 기반으로 최적화된 조건의 구리 나노와이어를 형성한 실시예 2에서는 평균 직경은 192nm, 평균 길이 68.10μm, 종횡비(aspect ration) 354.08, 최종 생산율 57%를 나타내었다.In Example 2, where copper nanowires were formed under optimized conditions based on Example 1, the average diameter was 192 nm, the average length was 68.10 μm, the aspect ratio was 354.08, and the final production yield was 57%.
평균 직경(nm)Average diameter (nm) | 평균 길이(μm)Average length (μm) | 종횡비Aspect ratio | 최종 생산율(%)Final production rate (%) | |
실시예 1Example 1 | 298.37298.37 | 56.2856.28 | 188.61188.61 | 5252 |
실시예 2Example 2 | 192.33192.33 | 68.1068.10 | 354.08354.08 | 5757 |
도 4는 본 발명의 일 비교예에 따른 용매 변경 후, 제작된 구리 형상 이미지를 도시한 것이다. 도 4를 참조하면, 비교예 1과 같이 Glycerol을 용매로서 제조된 구리는 입자 형상을 나타내었다.Fig. 4 illustrates an image of a copper shape produced after changing the solvent according to a comparative example of the present invention. Referring to Fig. 4, copper produced using glycerol as a solvent, as in Comparative Example 1, exhibited a particle shape.
도 5는 본 발명의 일 비교예에 따른 NaCl을 첨가하지 않았을 경우, 제작된 구리 형상 이미지를 도시한 것이다. 도 5를 참조하면, 비교예 2와 같이 NaCl을 사용하지 않은 경우 구리 옥살산의 불완전한 환원 및 불균일한 형상의 구리가 형성되었다.Figure 5 illustrates an image of a copper shape produced when NaCl was not added according to a comparative example of the present invention. Referring to Figure 5, when NaCl was not used as in Comparative Example 2, incomplete reduction of copper oxalate and copper of an uneven shape were formed.
XRD 분석XRD analysis
도 6은 본 발명의 일 실시예에 따른 구리 옥살산으로부터 제작된 구리 나노와이어 XRD 분석 결과를 도시한 것이다. 도 6을 참조하면, 실시예 2에 따른 구리 나노와이어는 (111), (200), (220)에서 구리 피크가 보여지는 것으로 보아, (111), (200), (220) 면을 가지는 FCC 구조의 구리 나노와이어임을 확인하였다.FIG. 6 illustrates the results of XRD analysis of copper nanowires manufactured from copper oxalic acid according to one embodiment of the present invention. Referring to FIG. 6, it was confirmed that the copper nanowire according to Example 2 was a copper nanowire having an FCC structure having (111), (200), (220) planes, as copper peaks were observed at (111), (200), and (220).
전술한 내용은 후술할 발명의 청구범위를 더욱 잘 이해할 수 있도록 본 발명의 특징과 기술적 장점을 다소 폭넓게 상술하였다. 본 발명이 속하는 기술 분야의 통상의 지식을 가진 자는 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The foregoing has broadly described the features and technical advantages of the present invention so that the scope of the claims to be described later may be better understood. Those skilled in the art will appreciate that the present invention may be implemented in other specific forms without changing the technical idea or essential features thereof. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive. The scope of the present invention is indicated by the claims described below rather than the detailed description above, and all changes or modifications derived from the claims and their equivalents should be construed as being included in the scope of the present invention.
Claims (6)
- 캡핑제를 포함하는 제 1용액을 형성하는 제 1단계;A first step of forming a first solution containing a capping agent;할로겐 촉매 및 환원제를 포함하는 제 2용액을 형성하는 제 2단계;A second step of forming a second solution containing a halogen catalyst and a reducing agent;구리 전구체 화합물을 포함하는 제 3용액을 형성하는 제 3단계;A third step of forming a third solution containing a copper precursor compound;상기 제 1 내지 3 용액을 혼합하고 가열하여 구리 나노와이어를 합성하는 제 4단계;를 포함하는, 종횡비가 1:180 이상인 고 종횡비의 구리 나노와이어의 제조방법.A method for producing high aspect ratio copper nanowires having an aspect ratio of 1:180 or more, comprising a fourth step of mixing and heating the first to third solutions to synthesize copper nanowires.
- 제 1항에 있어서,In paragraph 1,상기 제 1 내지 3단계는 용액 제조시 용매로서 폴리올 용매를 사용하는 것을 특징으로 하는 고 종횡비의 구리 나노와이어의 제조방법.The above steps 1 to 3 are a method for producing high aspect ratio copper nanowires, characterized in that a polyol solvent is used as a solvent in preparing a solution.
- 제 1항에 있어서,In paragraph 1,상기 4단계는 계면활성제를 추가로 첨가할 수 있는 것을 특징으로 하는 고 종횡비의 구리 나노와이어의 제조방법.The above 4 steps are a method for producing high aspect ratio copper nanowires, characterized in that a surfactant can be additionally added.
- 제 1 내지 3항 중 어느 한 항에 따른 제조방법으로 제조된 고 종횡비의 구리 나노와이어.A high aspect ratio copper nanowire manufactured by a manufacturing method according to any one of claims 1 to 3.
- 제 4항에 있어서,In paragraph 4,상기 구리 나노와이어는 이방성(anisotropy)인 것을 특징으로 하는 고 종횡비의 구리 나노와이어.A high aspect ratio copper nanowire characterized in that the copper nanowire is anisotropic.
- 제 4항에 있어서,In paragraph 4,상기 종횡비는 1:180 이상인 것을 특징으로 하는 고 종횡비의 구리 나노와이어.A high aspect ratio copper nanowire characterized by an aspect ratio of 1:180 or greater.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230012952A KR20240120364A (en) | 2023-01-31 | 2023-01-31 | Method for manufacturing high aspect ratio copper nanowires and copper nanowires accordingly |
KR10-2023-0012952 | 2023-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024162514A1 true WO2024162514A1 (en) | 2024-08-08 |
Family
ID=92146859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2023/002436 WO2024162514A1 (en) | 2023-01-31 | 2023-02-21 | Method for preparing copper nanowire having high aspect ratio and copper nanowire prepared thereby |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20240120364A (en) |
WO (1) | WO2024162514A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120066544A (en) * | 2010-12-14 | 2012-06-22 | 엘지이노텍 주식회사 | Nanowire and method for manufacturing the same |
KR20120115298A (en) * | 2009-12-07 | 2012-10-17 | 듀크 유니버시티 | Compositions and methods for growing copper nanowires |
KR101700212B1 (en) * | 2015-01-26 | 2017-01-26 | 덕산하이메탈(주) | Method for synthesizing metal nanowire, metal nanowire manufactured by the same, and transparent electrode and organic light emitting diode including the core-shell nanowire |
US20180323399A1 (en) * | 2015-01-26 | 2018-11-08 | Duksan Hi-Metal Co., Ltd. | Method of manufacturing metal nanowire and light-transmitting electrode and organic light-emitting device including metal nanowire manufactured thereby |
KR20190005242A (en) * | 2016-06-02 | 2019-01-15 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | Synthesis of ultra-thin metal nanowires using organic free radicals |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101719155B1 (en) | 2015-04-23 | 2017-04-04 | 한국과학기술연구원 | Metal nanowire, ink composition or transparent conductive film comprising the same, and the preparation method thereof |
-
2023
- 2023-01-31 KR KR1020230012952A patent/KR20240120364A/en unknown
- 2023-02-21 WO PCT/KR2023/002436 patent/WO2024162514A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120115298A (en) * | 2009-12-07 | 2012-10-17 | 듀크 유니버시티 | Compositions and methods for growing copper nanowires |
KR20120066544A (en) * | 2010-12-14 | 2012-06-22 | 엘지이노텍 주식회사 | Nanowire and method for manufacturing the same |
KR101700212B1 (en) * | 2015-01-26 | 2017-01-26 | 덕산하이메탈(주) | Method for synthesizing metal nanowire, metal nanowire manufactured by the same, and transparent electrode and organic light emitting diode including the core-shell nanowire |
US20180323399A1 (en) * | 2015-01-26 | 2018-11-08 | Duksan Hi-Metal Co., Ltd. | Method of manufacturing metal nanowire and light-transmitting electrode and organic light-emitting device including metal nanowire manufactured thereby |
KR20190005242A (en) * | 2016-06-02 | 2019-01-15 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | Synthesis of ultra-thin metal nanowires using organic free radicals |
Non-Patent Citations (1)
Title |
---|
KIM YU-KYUNG, YOO YOUNG-JIN, JEONG YUN-CHAE, CHOI JAE-YOUNG: "P-164: A facile synthesis of high aspect ratio Copper nanowire by using copper oxalate reduction method", FALL CONFERENCE OF THE MATERIALS RESEARCH SOCIETY OF KOREA; NOVEMBER 9 - 11, 2022, 1 November 2022 (2022-11-01) - 11 November 2022 (2022-11-11), Korea, pages 2 - 3, XP009557410 * |
Also Published As
Publication number | Publication date |
---|---|
KR20240120364A (en) | 2024-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101789213B1 (en) | Method of Manufacturing Silver-Coated Copper Nano Wire Having Core-Shell Structure by Chemical Reduction Method | |
KR101719155B1 (en) | Metal nanowire, ink composition or transparent conductive film comprising the same, and the preparation method thereof | |
CN1170648C (en) | Metal power and its preparation process and electric conductivity paste | |
WO2018226001A1 (en) | Silver particles and manufacturing method therefor | |
CN109095459B (en) | ZIF-67/graphene oxide and pyrolysis thereof to obtain hollow Co 3 O 4 Preparation method of graphene | |
CN101784352B (en) | Preparation method of copper particle composition | |
CN113716594B (en) | Hollow calcium carbonate nanoparticle and preparation method of hollow calcium carbonate nanoparticle mediated by dual additives | |
CN102350279A (en) | Method for preparing carbon nanotube (CNT)/layered double-metal hydroxide (LDH) compound | |
JP2008214695A (en) | Method for producing ultra-fine particle of silver | |
JP2009270146A (en) | Method for producing silver hyperfine particle | |
CN111822696B (en) | Monodisperse nano-copper particles for conductive ink and preparation method and application thereof | |
WO2024162514A1 (en) | Method for preparing copper nanowire having high aspect ratio and copper nanowire prepared thereby | |
KR101516953B1 (en) | Method for preparing copper nanowire, copper nanowire prepared by the same, ink composition, and method for preparing transparent conductive film | |
JP2014034697A (en) | Method for producing copper fine particle, conductive paste and method for producing conductive paste | |
KR100851815B1 (en) | A method of preparing nano silver powder | |
WO2019177205A1 (en) | Anisotropic 2d silver nano plates and method for manufacturing same | |
CN110078116B (en) | Perovskite CsPbBr3Quantum dot and preparation method and application thereof | |
WO2022209267A1 (en) | Copper particles and method for manufacturing same | |
KR20130116671A (en) | Manufacturing methods of colloidal cerium oxides | |
WO2021249298A1 (en) | Preparation method for lead nanowire | |
CN112846213B (en) | Preparation method of low-oxygen high-dispersion nano spherical cobalt powder | |
JP2013023419A (en) | BOEHMITE NANOROD AND METHOD FOR PRODUCING THE SAME, ALUMINA NANOROD AND METHOD FOR PRODUCING THE SAME, AND CuAlO2 FILM AND METHOD FOR PRODUCING THE SAME | |
CN113926487A (en) | Fullerol/palladium nano composite photocatalyst and preparation method and application thereof | |
JP2018509524A (en) | Silver-coated copper flakes and method for producing the same | |
CN116081668B (en) | Boehmite sol dispersing agent, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23920066 Country of ref document: EP Kind code of ref document: A1 |